Your browser doesn't support javascript.
loading
A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates.
Citron, Michael P; Patel, Manishkumar; Purcell, Mona; Lin, Shu-An; Rubins, Daniel J; McQuade, Paul; Callahan, Cheryl; Gleason, Alexa; Petrescu, Ioan; Knapp, Walter; Orekie, Chinedu; Chamarthy, Sai; Wen, Zhiyun; Touch, Sinoeun; Pine, Matthew; Fontenot, Jane; Douglas, Cameron; Liang, Xiaoping; Espeseth, Amy S.
Afiliación
  • Citron MP; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States. Electronic address: michael_citron@merck.com.
  • Patel M; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Purcell M; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Lin SA; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Rubins DJ; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • McQuade P; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Callahan C; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Gleason A; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Petrescu I; Safety Assessment and Laboratory Animal Sciences, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Knapp W; Safety Assessment and Laboratory Animal Sciences, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Orekie C; Biopharmaceutics & Specialty DF/Development, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Chamarthy S; Biopharmaceutics & Specialty DF/Development, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Wen Z; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Touch S; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Pine M; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Fontenot J; The University of Louisiana New Iberia Research Center, New Iberia, LA 70560, United States.
  • Douglas C; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Liang X; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
  • Espeseth AS; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
Vaccine ; 36(20): 2876-2885, 2018 05 11.
Article en En | MEDLINE | ID: mdl-29599087
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Administración Intranasal / Chlorocebus aethiops / Sigmodontinae / Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Administración Intranasal / Chlorocebus aethiops / Sigmodontinae / Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2018 Tipo del documento: Article